Drugmakers scurry to secure liquidity this year

Published: 2012-03-21 07:00:00

Updated: 2012-03-21 07:00:00

A growing number of pharmaceutical companies remain vigilant and secure enough liquidity for unfavorable business conditions due to a variety of negative factor that may affect the local pharmaceutical industry.

A report released by Yakup.com, a pharmaceutical information company, showed that ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK